SE8803870A - - Google Patents

Info

Publication number
SE8803870A
SE8803870A SE8803870A SE8803870A SE8803870A SE 8803870 A SE8803870 A SE 8803870A SE 8803870 A SE8803870 A SE 8803870A SE 8803870 A SE8803870 A SE 8803870A SE 8803870 A SE8803870 A SE 8803870A
Authority
SE
Sweden
Prior art keywords
pct
date
sec
detection
body fluid
Prior art date
Application number
SE8803870A
Other versions
SE8803870D0 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to SE19888803870A priority Critical patent/SE8803870D0/en
Publication of SE8803870A publication Critical patent/SE8803870A/xx
Publication of SE8803870D0 publication Critical patent/SE8803870D0/en
Priority to AT89911909T priority patent/ATE100207T1/en
Priority to JP01511118A priority patent/JP3117695B2/en
Priority to PCT/SE1989/000612 priority patent/WO1990004790A1/en
Priority to DE89911909T priority patent/DE68912342T2/en
Priority to AU44815/89A priority patent/AU639666B2/en
Priority to EP89911909A priority patent/EP0440700B1/en
Priority to US07/678,974 priority patent/US5629146A/en
Priority to FI912050A priority patent/FI97426C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PCT No. PCT/SE89/00612 Sec. 371 Date Jun. 25, 1991 Sec. 102(e) Date Jun. 25, 1991 PCT Filed Oct. 30, 1990 PCT Pub. No. WO90/04790 PCT Pub. Date May 3, 1990Method for detection of infection with human papillomavirus (HPV) for diagnostic purposes, particularly for diagnosing carcinoma, or pre-stages thereof, or the risk of development of carcinoma. The detection is effected on a body fluid, particularly on a secretion from cervix uteri, by ascertaining the presence of IgA, IgG and IgM antibodies against papillomavirus virions, including individual virion proteins or peptides thereof, in the body fluid.
SE19888803870A 1988-10-28 1988-10-28 METHOD FOR DETECTION OF HUMAN PAPILLOMAVIRUS (HPV) FOR DIAGNOSTIC PURPOSES SE8803870D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE19888803870A SE8803870D0 (en) 1988-10-28 1988-10-28 METHOD FOR DETECTION OF HUMAN PAPILLOMAVIRUS (HPV) FOR DIAGNOSTIC PURPOSES
AT89911909T ATE100207T1 (en) 1988-10-28 1989-10-30 METHODS OF DETECTING HUMAN PAPILLOMAVIRUS (HPV) FOR DIAGNOSIS PURPOSES.
JP01511118A JP3117695B2 (en) 1988-10-28 1989-10-30 Method for preventing papilloma virus (HPV) in human body for medical purposes
PCT/SE1989/000612 WO1990004790A1 (en) 1988-10-28 1989-10-30 Method for detection of human papillomavirus (hpv) for diagnostic purposes
DE89911909T DE68912342T2 (en) 1988-10-28 1989-10-30 METHOD FOR DETECTING HUMAN PAPILLOMAVIRUS (HPV) FOR DIAGNOSTIC PURPOSES.
AU44815/89A AU639666B2 (en) 1988-10-28 1989-10-30 Method for detection of human papillomavirus (hpv) for diagnostic purposes
EP89911909A EP0440700B1 (en) 1988-10-28 1989-10-30 Method for detection of human papillomavirus (hpv) for diagnostic purposes
US07/678,974 US5629146A (en) 1988-10-28 1990-10-30 Method for detection of human papillomavirus (HPV) for diagnostic purposes
FI912050A FI97426C (en) 1988-10-28 1991-04-26 Procedure for detecting papillomavirus (HPV) in humans for diagnostic use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19888803870A SE8803870D0 (en) 1988-10-28 1988-10-28 METHOD FOR DETECTION OF HUMAN PAPILLOMAVIRUS (HPV) FOR DIAGNOSTIC PURPOSES

Publications (2)

Publication Number Publication Date
SE8803870A true SE8803870A (en) 1988-10-28
SE8803870D0 SE8803870D0 (en) 1988-10-28

Family

ID=20373771

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19888803870A SE8803870D0 (en) 1988-10-28 1988-10-28 METHOD FOR DETECTION OF HUMAN PAPILLOMAVIRUS (HPV) FOR DIAGNOSTIC PURPOSES

Country Status (8)

Country Link
US (1) US5629146A (en)
EP (1) EP0440700B1 (en)
JP (1) JP3117695B2 (en)
AU (1) AU639666B2 (en)
DE (1) DE68912342T2 (en)
FI (1) FI97426C (en)
SE (1) SE8803870D0 (en)
WO (1) WO1990004790A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411857A (en) * 1985-07-31 1995-05-02 Institut Nationale De La Sante Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections
FR2586428B1 (en) * 1985-08-26 1988-11-25 Pasteur Institut POLYPEPTIDES AND ANTIBODIES, CHARACTERISTICS OF PAPILLOMAVIRUS AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS, PREVENTION AND / OR CONTROL OF PAPILLOMAVIRUS INFECTIONS
CA2038581A1 (en) * 1990-03-20 1991-09-21 Martin Muller Seroreactive epitopes of human papillomavirus (hpv) 16 proteins
SE9001705D0 (en) * 1990-05-11 1990-05-11 Medscand Ab SET FOR DIAGNOSTICS OF VIRUS BREAKING TUMORS BY IMMUNOASSAY
US5932412A (en) * 1990-05-11 1999-08-03 Euro-Diagnostica Ab Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes
US5763164A (en) * 1993-04-16 1998-06-09 Northwestern University Immunogenic cancer proteins and peptides and methods of use
GB9313556D0 (en) * 1993-07-01 1993-08-18 British Tech Group Synthetic peptides of human papillomavirus
GB2279651A (en) * 1993-07-01 1995-01-11 British Tech Group Synthetic peptides of human papillomavirus
GB9420146D0 (en) 1994-10-06 1994-11-23 Cancer Res Campaign Tech Papillomavirus vaccine
SE9501512D0 (en) * 1995-04-24 1995-04-24 Euro Diagnostica Ab Synthetic peptide-defined eptopes useful for papillomavirus vaccination
AU726047B2 (en) 1995-11-15 2000-10-26 Gen-Probe Incorporated Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
DE19925199A1 (en) * 1999-06-01 2000-12-07 Medigene Ag Cytotoxic T cell epitopes of the papillomavirus L1 protein and their use in diagnostics and therapy
WO2001077142A1 (en) * 2000-04-05 2001-10-18 Impact Diagnostics, Inc. Immunological methodology for discerning human papillomavirus
DE10059631A1 (en) * 2000-12-01 2002-07-18 Medigene Ag T-cell epitopes of the papillomavirus L1 and E7 proteins and their use in diagnostics and therapy
US6933123B2 (en) * 2001-04-05 2005-08-23 Yao Xiong Hu Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers
WO2003014140A1 (en) * 2001-08-09 2003-02-20 Board Of Trustees Of The University Of Arkansas Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer
CO5770113A1 (en) * 2006-04-28 2007-06-29 Fundacion Inst De Inmunologia De Colombia PEPTIDES TO DETECT OR INDUCE THE PRODUCTION OF ANTIBODIES ANTI THE HUMAN PAILOMA VIRUS, ANTI THE PROTEIN L1 OR ANTI PEPTIDES OF THIS PROTEIN
WO2010118424A2 (en) 2009-04-10 2010-10-14 The Johns Hopkins University Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines
DE102011053741A1 (en) * 2011-09-19 2013-03-21 Ralf Hilfrich A method of verifying self-healing by the immune system of a human papillomavirus infected human
RU2520710C1 (en) * 2012-12-10 2014-06-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Челябинская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО ЧелГМА Минздравсоцразвития России) Method for prediction of persistence of oncogenic human papilloma virus in cervical epithelium
CN117054648A (en) * 2023-07-26 2023-11-14 广东省一鼎生物技术有限公司 Kit for detecting HPV IgM antibody and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB235187A (en) * 1924-06-07 1926-06-03 Robert Howe Gould Improvements in burglar and like alarms
AU554097B2 (en) * 1983-07-01 1986-08-07 Phillip John Baird Papillomavirus virion orantigen reagent and assay method
JPS6089755A (en) * 1983-07-01 1985-05-20 フイリツプ・ジヨン・ベア−ド Reagent for diagnosis and manufacture thereof and diagnostic method using said manufacture
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
EP0217919B1 (en) * 1985-04-04 1992-08-05 Georgetown University Type-specific papillomavirus dna sequences and peptides
FR2586428B1 (en) * 1985-08-26 1988-11-25 Pasteur Institut POLYPEPTIDES AND ANTIBODIES, CHARACTERISTICS OF PAPILLOMAVIRUS AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS, PREVENTION AND / OR CONTROL OF PAPILLOMAVIRUS INFECTIONS
WO1987005630A1 (en) * 1986-03-21 1987-09-24 Institut Pasteur Determined dna sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
US4777239A (en) * 1986-07-10 1988-10-11 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic peptides of human papilloma virus

Also Published As

Publication number Publication date
JPH04506562A (en) 1992-11-12
DE68912342T2 (en) 1994-05-05
WO1990004790A1 (en) 1990-05-03
AU4481589A (en) 1990-05-14
DE68912342D1 (en) 1994-02-24
FI97426B (en) 1996-08-30
JP3117695B2 (en) 2000-12-18
US5629146A (en) 1997-05-13
EP0440700B1 (en) 1994-01-12
FI97426C (en) 1996-12-10
AU639666B2 (en) 1993-08-05
SE8803870D0 (en) 1988-10-28
EP0440700A1 (en) 1991-08-14
FI912050A0 (en) 1991-04-26

Similar Documents

Publication Publication Date Title
SE8803870A (en)
EP0110560A3 (en) Ophthalmic instrument for measuring intraocular fluid pressure
DK0610250T4 (en) Vaccine with Porcine Reproductive Respiratory Syndrome (PRRS) and diagnosis thereof
LU91396I2 (en) "Combination of recombinant human papillomavirus L1 protein types 6,11,16 and 18" -Gardasil / Silgard
MY104208A (en) Non-a, non-b hepatitis virus antigen peptide.
SE8200011L (en) DEVICE AND SET FOR SEATING SAMPLING PRESSURE
DK0523395T3 (en) Seroreactive regions on proteins E1 and E2 in HPV 16
ATE71271T1 (en) APPARATUS FOR THE SIMULTANEOUS DETERMINATION OF FLOW AND PRESSURE IN THE OCULAR AREAS.
PL309637A1 (en) Diagnostic test and therapy for demyelination diseases such as multiple sclerosis
KR910019641A (en) Serum Reactive Epitopes on Proteins of Human Papilloma Virus (HPV) 18
EP0561885A4 (en) Subunit papillomavirus vaccine and peptides for use therein
FR2556586B1 (en) DEVICE FOR THE FLOW OF URINE FROM UROSTOMIES
ES2040599T3 (en) DIAPHRAGM VALVE.
EP0560776A4 (en) The gene encoding equine herpesvirus type 1 glycoprotein d, its gene product, antibodies and their uses
GR3021452T3 (en) Method for the detection of gastric epithelial damage.
Ho et al. IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients.
DE3272729D1 (en) Hepatitis-a viruses adapted to human fibroblast cells
WO1999024466A3 (en) Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes
GOLDSTEIN et al. Hemophilus influenzae pyarthrosis in an adult
Coughlan et al. Antibody activity to type 1 and type 2 herpes simplex virus in human cervical mucus
Hadar et al. Detection of specific IgA antibodies to varicella zoster virus in serum of patients with Ramsay Hunt syndrome
EP0808846A3 (en) Peptides which react with antiboby representing the prognostic marker for HIV disease progression
Zikria et al. Multiple organ failure syndrome
IT1273996B (en) Use of antibodies which recognize the 90K protein in the clinical diagnosis and monitoring of patients suffering from viral hepatitis
Tsibinogina et al. An EIA diagnostic test-system for the detection of anti-HAV IgM in serum samples.